Skip to main content

Vertex Pharmaceuticals Inc

VRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000875320

In the last 90 days, Vertex Pharmaceuticals Inc insiders filed 0 open-market purchases and 3 sales; 1,763 institutions reported holding it in 13F filings for Q2 2026, worth $119.7B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Vertex Pharmaceuticals Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
3 filings
3 insiders, $2.00M in total
Insiders trading
3
Net value
−$2.00M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Vertex Pharmaceuticals Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Vertex Pharmaceuticals Inc
NameTitleLast reported holdingLast filingFilings, past year
van Grunsven JasperEVP, CP and NPPO8,682Sep 10, 20261
Ambrose KristenSVP & Chief Accounting Officer11,624Sep 1, 20267
Sachs Bruce IDirector39,000Aug 31, 20266
Tatsis OuraniaEVP, Chief Reg. & Quality Off.53,572Jul 23, 20269
Sachdev AmitEVP Chief Patient & Ext Af Off66,512Jul 23, 20267
Garber Alan MDirector7,344Jul 17, 20263
McKechnie DuncanEVP, Chief Commercial Officer11,001Jul 7, 20268
Liu JoyEVP and Chief Legal Officer19,131Jul 6, 20265
Bozic CarmenEVP and CMO15,337Jun 30, 202615
Bunnage Mark E.EVP, Chief Scientific Officer7,284May 19, 20265
Carney LloydDirector6,315May 5, 20262
Lagarde MichelDirector1,132May 5, 20261
Upadhyay SuketuDirector1,558May 5, 20264
Bhatia Sangeeta N.Director4,924May 5, 20262
McKenzie DianaDirector2,378May 5, 20261
Schneider JenniferDirector1,394May 5, 20261
Thornberry NancyDirector2,109May 5, 20261
Kewalramani ReshmaCEO & President98,278Mar 3, 20266
Wagner Charles F JrEVP, CO & FO47,042Feb 26, 20267
Leiden Jeffrey MExecutive Chairman34,797Feb 26, 20265
Biller JonathanEVP and Chief Legal Officer13,659Feb 26, 20267
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.18,432Feb 26, 20266
Altshuler DavidEVP, Chief Scientific Officer34,477Jan 26, 20261
Arbuckle Stuart AEVP, COO63,368Jul 2, 20250
Kearney Terrence CDirector6,536May 3, 20240
Sanna BastianoEVP, Cell & Genetic Therapies32,038May 9, 20230
McGlynn Margaret GDirector178May 3, 20230
Lee YuchunDirector1,875May 3, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 19, 2025 (view filing)Nov 172 daysAtkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.SSale−2.50K$434.58−$1.09M−12.9%16.9K after10b5-1
Nov 17, 2025 (view filing)Nov 13-144 daysLeiden Jeffrey MExecutive ChairmanSSale−73.3K$440.60−$32.3M−75.3%24.0K after5 lots10b5-1
Oct 3, 2025 (view filing)Oct 21 dayBiller JonathanEVP and Chief Legal OfficerSSale−694$404.21−$280.5K−4.2%15.7K after10b5-1
Aug 29, 2025 (view filing)Aug 272 daysBhatia Sangeeta N.DirectorSSale−266$386.69−$102.9K−5.5%4.57K after10b5-1
Aug 7, 2025 (view filing)Aug 61 dayKewalramani ReshmaCEO & PresidentPPurchase+10.0K$389.58+$3.90M+9.4%116.0K after2 lots
Aug 7, 2025 (view filing)Aug 61 daySachs Bruce IDirectorPPurchase+5.00K$389.68+$1.95M+12.5%45.0K after2 lots
May 19, 2025 (view filing)May 154 daysAltshuler DavidEVP, Chief Scientific OfficerSSale−52$424.69−$22.1K−0.2%23.3K after10b5-1
May 5, 2025 (view filing)May 23 daysBhatia Sangeeta N.DirectorSSale−400$505.86−$202.3K−7.6%4.83K after10b5-1
Mar 17, 2025 (view filing)Mar 134 daysAltshuler DavidEVP, Chief Scientific OfficerSSale−3.23K$510.00−$1.65M−12.2%23.3K after10b5-1
Mar 12, 2025 (view filing)Mar 102 daysWagner Charles F JrEVP & Chief Financial OfficerSSale−3.30K$500.00−$1.65M−6.0%51.7K after10b5-1
Mar 12, 2025 (view filing)Mar 102 daysTatsis OuraniaEVP, Chief Reg. & Quality Off.SSale−3.24K$499.99−$1.62M−6.0%51.2K after10b5-1
Mar 12, 2025 (view filing)Mar 102 daysAltshuler DavidEVP, Chief Scientific OfficerSSale−3.23K$500.00−$1.62M−10.9%26.5K after10b5-1
Mar 6, 2025 (view filing)Mar 42 daysTatsis OuraniaEVP, Chief Reg. & Quality Off.SSale−4.06K$485.49−$1.97M−6.9%54.5K after10b5-1
Mar 5, 2025 (view filing)Mar 32 daysAltshuler DavidEVP, Chief Scientific OfficerSSale−3.23K$490.00−$1.58M−9.8%29.7K after10b5-1
Feb 28, 2025 (view filing)Feb 271 dayTatsis OuraniaEVP, Chief Reg. & Quality Off.SSale−530$475.34−$251.9K−0.9%58.5K after10b5-1
Feb 28, 2025 (view filing)Feb 271 dayAtkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.SSale−2.65K$475.34−$1.26M−12.0%19.4K after10b5-1
Feb 28, 2025 (view filing)Feb 271 dayAltshuler DavidEVP, Chief Scientific OfficerSSale−1.27K$480.00−$610.6K−3.7%33.0K after10b5-1
Feb 26, 2025 (view filing)Feb 251 dayTatsis OuraniaEVP, Chief Reg. & Quality Off.SSale−354$480.95−$170.3K−0.5%64.0K after10b5-1
Feb 26, 2025 (view filing)Feb 251 dayAtkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.SSale−1.77K$480.95−$849.8K−6.7%24.5K after10b5-1
Feb 26, 2025 (view filing)Feb 251 dayAmbrose KristenSVP & Chief Accounting OfficerSSale−884$480.95−$425.2K−8.9%9.09K after10b5-1
Feb 26, 2025 (view filing)Feb 251 dayAltshuler DavidEVP, Chief Scientific OfficerSSale−848$480.95−$407.8K−2.1%40.2K after10b5-1
Feb 24, 2025 (view filing)Feb 204 daysAltshuler DavidEVP, Chief Scientific OfficerSSale−1.11K$480.00−$533.3K−2.4%45.0K after10b5-1
Feb 19, 2025 (view filing)Feb 181 dayTatsis OuraniaEVP, Chief Reg. & Quality Off.SSale−244$455.06−$111.0K−0.4%67.7K after10b5-1
Feb 19, 2025 (view filing)Feb 181 dayBiller JonathanEVP and Chief Legal OfficerSSale−1.66K$455.06−$754.0K−8.6%17.6K after10b5-1
Feb 19, 2025 (view filing)Feb 181 dayAmbrose KristenSVP & Chief Accounting OfficerSSale−671$455.06−$305.3K−5.9%10.8K after10b5-1
Feb 12, 2025 (view filing)Feb 111 dayTatsis OuraniaEVP, Chief Reg. & Quality Off.SSale−310$459.83−$142.5K−0.5%64.0K after10b5-1
Feb 12, 2025 (view filing)Feb 111 dayBiller JonathanEVP and Chief Legal OfficerSSale−3.43K$459.87−$1.58M−17.4%16.3K after10b5-1
Feb 12, 2025 (view filing)Feb 111 dayAtkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.SSale−1.75K$459.83−$803.3K−7.0%23.2K after10b5-1
Feb 12, 2025 (view filing)Feb 111 dayAmbrose KristenSVP & Chief Accounting OfficerSSale−1.38K$459.83−$632.7K−12.1%9.95K after10b5-1
Nov 19, 2024 (view filing)Nov 154 daysAltshuler DavidEVP, Chief Scientific OfficerSSale−15$478.56−$7.18K−0.1%25.8K after10b5-1
Nov 13, 2024 (view filing)Nov 112 daysWagner Charles F JrEVP & Chief Financial OfficerSSale−3.00K$518.27−$1.55M−6.4%44.1K after10b5-1
Nov 12, 2024 (view filing)Nov 84 daysKewalramani ReshmaCEO & PresidentSSale−15.2K$515.00−$7.83M−16.7%75.8K after10b5-1
Oct 3, 2024 (view filing)Oct 21 dayBiller JonathanEVP and Chief Legal OfficerSSale−999$461.66−$461.2K−5.7%16.7K after10b5-1
Sep 4, 2024 (view filing)Aug 305 daysLeiden Jeffrey MExecutive ChairmanSSale−3.78K$499.00−$1.89M−27.5%9.99K after10b5-1
Sep 4, 2024 (view filing)Aug 305 daysBhatia Sangeeta N.DirectorSSale−646$500.00−$323.0K−12.7%4.43K after10b5-1
Aug 12, 2024 (view filing)Aug 84 daysBhatia Sangeeta N.DirectorSSale−1.29K$466.29−$602.4K−22.6%4.43K after10b5-1
Aug 8, 2024 (view filing)Aug 71 dayBozic CarmenEVP and CMOSSale−2.28K$476.75−$1.09M−8.9%23.3K after10b5-1
Aug 2, 2024 (view filing)Aug 11 daySachs Bruce IDirectorSSale−5.29K$508.00−$2.69M−11.7%40.0K after10b5-1
Aug 1, 2024 (view filing)Jul 302 daysKewalramani ReshmaCEO & PresidentSSale−15.2K$505.00−$7.68M−14.3%91.0K after10b5-1
Jul 25, 2024 (view filing)Jul 241 dayBozic CarmenEVP and CMOSSale−2.28K$488.46−$1.11M−8.2%25.5K after10b5-1
Jul 24, 2024 (view filing)Jul 222 daysKewalramani ReshmaCEO & PresidentSSale−15.2K$497.00−$7.56M−12.5%106.2K after10b5-1
Jul 12, 2024 (view filing)Jul 102 daysBozic CarmenEVP and CMOSSale−2.28K$487.34−$1.11M−7.6%27.8K after10b5-1
Jun 28, 2024 (view filing)Jun 262 daysBozic CarmenEVP and CMOSSale−2.28K$471.72−$1.08M−7.0%30.1K after10b5-1
Jun 13, 2024 (view filing)Jun 121 dayBozic CarmenEVP and CMOSSale−2.28K$478.00−$1.09M−6.6%32.4K after10b5-1
Jun 13, 2024 (view filing)Jun 121 dayAtkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.SSale−7.29K$478.00−$3.48M−31.3%16.0K after10b5-1
Jun 5, 2024 (view filing)Jun 32 daysWagner Charles F JrEVP & Chief Financial OfficerSSale−3.25K$460.00−$1.50M−6.5%47.1K after10b5-1
Jun 5, 2024 (view filing)Jun 32 daysTatsis OuraniaEVP, Chief Reg. & Quality Off.SSale−2.17K$460.00−$1.00M−4.2%49.1K after10b5-1
Jun 3, 2024 (view filing)May 30-314 daysTatsis OuraniaEVP, Chief Reg. & Quality Off.SSale−4.60K$441.99−$2.03M−8.2%51.3K after2 lots10b5-1
May 31, 2024 (view filing)May 292 daysBozic CarmenEVP and CMOSSale−2.28K$445.56−$1.02M−6.2%34.7K after10b5-1
May 30, 2024 (view filing)May 282 daysWagner Charles F JrEVP & Chief Financial OfficerSSale−3.25K$454.79−$1.48M−6.1%50.4K after10b5-1